Recombine, Inc., a leading player in the biotechnology sector, is headquartered in the United States and operates across various regions, focusing on innovative solutions in genetic testing and analysis. Founded in 2013, the company has achieved significant milestones, including the development of advanced genomic technologies that enhance personalised medicine. Recombine's core offerings include comprehensive genetic testing services that empower healthcare providers and patients with actionable insights. What sets Recombine apart is its commitment to accuracy and user-friendly interfaces, making genetic information accessible and understandable. With a strong market position, Recombine has garnered recognition for its contributions to the field, positioning itself as a trusted partner in the evolving landscape of genomics and personalised healthcare.
How does Recombine, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Recombine, Inc.'s score of 39 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Recombine, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of The Cooper Companies, Inc., which may influence its climate commitments and reporting practices. As of now, Recombine, Inc. has not established any documented reduction targets or climate pledges. This lack of specific initiatives suggests that the company may still be in the early stages of developing its sustainability strategy. Given the absence of direct emissions data and reduction commitments, it is essential for Recombine, Inc. to align with industry standards and consider adopting science-based targets to enhance its climate action efforts. This would not only contribute to global emissions reduction goals but also improve its corporate sustainability profile within the industry.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 29,747,000 | 00,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 33,442,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Recombine, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

